# US Atherectomy Devices Market > US Atherectomy Devices Market Research Report: Size, Share, Trend Analysis By Types (Directional Atherectomy Devices, Orbital Atherectomy Devices, Laser Atherectomy Devices, Rotational Atherectomy Devices), By Applications (Coronary Artery Disease, Peripheral Artery Disease, Carotid Artery Disease), By End Users (Hospitals, Cardiac Catheterization Labs, Ambulatory Surgical Centers) and By Material (Stainless Steel, Polymers, Composites) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 6.55% - **2024:** $ 427.81 Million - **2025:** $ 455.83 Million - **2035:** $ 860 Million - **Key Players:** Boston Scientific (US), Medtronic (US), Abbott Laboratories (US), Cardiovascular Systems Inc (US), Spectranetics (US), B. Braun Melsungen AG (DE), Terumo Corporation (JP), Philips (NL) **Report ID:** MRFR/HC/17103-HCR · **Pages:** 100 · **Author:** Rahul Gotadki & Garvit Vyas · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-atherectomy-devices-market-18631 --- ## Market Summary ## **US Atherectomy Devices Market Overview** As per MRFR analysis, the US Atherectomy Devices Market Size was estimated at 409.15 (USD Million) in 2023. The US Atherectomy Devices Market Industry is expected to grow from 428.65(USD Million) in 2024 to 700.17 (USD Million) by 2035. The US Atherectomy Devices Market CAGR (growth rate) is expected to be around 4.562% during the forecast period (2025 - 2035). ### **Key US Atherectomy Devices Market Trends Highlighted** The US Atherectomy Devices Market is experiencing several important trends shaped by advancements in technology and increasing healthcare awareness. One key market driver is the rising incidence of cardiovascular diseases, which has led to a significant demand for minimally invasive surgical techniques. The US healthcare system is increasingly focusing on patient comfort and quick recovery, which promotes the growth of atherectomy devices that offer such benefits. With the aging population in the US, there is a growing need for effective treatment options for peripheral artery diseases, which is further propelling market growth. Recent innovations in atherectomy technology, including the development of more precise and safer devices, have emerged as a vital trend. Physicians are now able to use devices that provide enhanced visualization and control during procedures, significantly improving patient outcomes. In addition, there is an increased emphasis on clinical education, ensuring healthcare professionals are well-equipped to utilize these advanced devices properly. Opportunities for growth are also poised in the US market due to an increasing number of FDA-approved atherectomy devices, leading to more choices for healthcare providers and patients alike. Furthermore, the shift towards value-based care in the US healthcare landscape emphasizes the importance of effective treatment methodologies that not only enhance patients' quality of life but also reduce long-term healthcare costs. The ongoing collaboration between manufacturers and healthcare institutions aims to address the emerging needs of the market, making atherectomy devices an essential part of cardiovascular treatment strategies in the US. As healthcare policies evolve, the focus on innovation and improved patient care will continue to shape the landscape of the US Atherectomy Devices Market. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **US Atherectomy Devices Market Drivers** #### **Increasing Prevalence of Cardiovascular Diseases** The rising incidence of cardiovascular diseases is a significant driver for the growth of the US Atherectomy Devices Market Industry. According to the Centers for Disease Control and Prevention (CDC), about 697,000 people die from heart disease each year in the United States, representing one in every five deaths. Additionally, the American Heart Association reported that in 2020, approximately 18.2 million adults aged 20 and older had coronary artery disease, which necessitates surgical interventions, including atherectomy procedures. The increasing need for effective treatment options, along with the introduction of innovative atherectomy devices by leading manufacturers such as Boston Scientific Corporation and Medtronic, is expected to contribute significantly to market growth. Furthermore, a gradual shift towards minimally invasive procedures enhances the demand for atherectomy tools, thereby boosting the overall market potential. #### **Technological Advancements in Atherectomy Devices** Technological innovations play a crucial role in expanding the US Atherectomy Devices Market Industry. The development of advanced atherectomy devices, such as laser atherectomy systems and rotational devices, enhances the efficacy and safety of procedures. For example, the US Food and Drug Administration (FDA) has been actively approving new atherectomy devices that improve patient outcomes and reduce complications. The Boston Scientific's Diamondback 360 and Spectranetics' Turbo-Tandem Catheter represent significant advancements that provide superior plaque removal capabilities. These innovations not only increase the efficiency of procedures but also attract more healthcare providers to adopt these devices, further driving market growth. #### **Rising Geriatric Population** The increasing geriatric population in the US is a notable driver for the US Atherectomy Devices Market Industry. The U.S. Census Bureau projects that by 2030, all baby boomers will be over the age of 65, creating a demographic shift leading to an increased prevalence of age-related diseases, specifically cardiovascular conditions. The National Council on Aging has indicated that two-thirds of older adults have multiple chronic conditions, a considerable factor that enhances the demand for atherectomy procedures. This demographic trend underscores the need for efficient, innovative treatment solutions, making the atherectomy devices market increasingly relevant and essential for addressing the healthcare needs of the aging population. #### **Growing Awareness and Adoption of Minimally Invasive Procedures** Growing awareness regarding minimally invasive procedures significantly propels the US [Atherectomy Devices](../../../reports/atherectomy-devices-market-7322) Market Industry. As patient preferences shift towards less invasive surgical options due to shorter recovery times and reduced complications, healthcare providers are increasingly adopting atherectomy procedures. The American College of Cardiology notes that there has been a steady increase in the utilization of such procedures over the past decade. Furthermore, during the COVID-19 pandemic, many patients delayed open surgical procedures, leading to increased interest and investment in less invasive techniques. This trend is encouraging medical professionals to promote atherectomy devices more, driven by advancements in technology and improved outcomes associated with these procedures. ### **US Atherectomy Devices Market Segment Insights** #### **Atherectomy Devices Market Type Insights** The US Atherectomy Devices Market is characterized by a diverse range of types that cater to varying clinical needs in the treatment of arterial diseases. Each type of device has distinct functionalities and applications, contributing to specific treatment processes. Directional atherectomy devices are particularly noted for their capability to selectively remove plaque from arterial walls while preserving the healthy surrounding tissue, making them a favored choice among clinicians for treating lesions in peripheral arteries. Similarly, orbital atherectomy devices excel in treating calcified lesions by utilizing a unique grinding mechanism, effectively allowing for smoother arterial passage and improved blood flow. The laser atherectomy devices have gained traction due to their precision in vaporizing plaque with minimal damage to surrounding structures, significantly improving procedural outcomes. Furthermore, rotational atherectomy devices play a vital role by offering the ability to treat complex lesions that are resistant to conventional balloon angioplasty, thereby enhancing the overall efficacy of revascularization procedures. The rising prevalence of cardiovascular diseases in the US continues to drive demand for these types of atherectomy devices. Furthermore, advancements in technology foster innovations, enabling better outcomes and expanding the indications for each type. The regulatory environment also supports the introduction of innovative devices, further propelling overall market development. The significant growth potential within the US Atherectomy Devices Market indicates that each type will play an increasingly important role in addressing patient needs and improving overall cardiovascular health outcomes. The enhancement and differentiation in these device types reflect a broader trend toward personalized treatment options, which cater to individual patient anatomy and conditions, ultimately contributing to improved patient quality of life and outcomes. Overall, the US Atherectomy Devices Market segmentation exhibits a dynamic landscape where each device type contributes distinctly to market growth and reflects the evolving technology and treatment paradigms in the realm of vascular interventions. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review #### **Atherectomy Devices Market Application Insights** The US Atherectomy Devices Market is significantly influenced by various applications, including Coronary Artery Disease, Peripheral Artery Disease, and Carotid Artery Disease. Coronary Artery Disease, being one of the leading causes of mortality in the United States, drives innovation and demand for atherectomy devices, as they provide minimally invasive solutions to remove plaque build-up in the coronary arteries. Peripheral Artery Disease is on the rise, often associated with aging demographics and lifestyle diseases, making it crucial to improve the treatment landscape and enhance patient quality of life. Meanwhile, Carotid Artery Disease presents a significant concern due to its association with stroke risk; thus, the effectiveness of atherectomy procedures can significantly impact patient outcomes. The increasing prevalence of these conditions is coupled with advancements in technology, which present opportunities for improved procedural success and patient safety. Continuous Research and Development in atherectomy devices aim to enhance their efficacy and adopt new materials and techniques, addressing ongoing challenges such as device-related complications and efficacy discrepancies across demographics. The US Atherectomy Devices Market segmentation reflects a focused approach towards addressing these health concerns, making it an important sector in cardiovascular care. #### **Atherectomy Devices Market End User Insights** The US Atherectomy Devices Market is significantly driven by the End User segment, which incorporates various healthcare settings including Hospitals, Cardiac Catheterization Labs, and Ambulatory Surgical Centers. Hospitals are essential in this market as they serve a vast patient population and often have the most advanced medical technology and specialists available, enabling effective treatment procedures using atherectomy devices. Cardiac Catheterization Labs play a crucial role in the diagnosis and treatment of cardiovascular diseases, making them an important environment for atherectomy procedures; the increasing prevalence of coronary artery diseases further supports the growth of this segment. Ambulatory Surgical Centers are gaining traction due to their ability to provide outpatient procedures, thus offering patients a less invasive option with quicker recovery times, which is becoming increasingly preferred in the healthcare industry. The amalgamation of these facilities contributes to the overall efficiency in managing cardiovascular diseases in the US, highlighting their significance in the US Atherectomy Devices Market revenue. As trends shift towards minimally invasive procedures, the demand for atherectomy devices is anticipated to rise, providing ample opportunities for growth within these End User categories. The ability of these facilities to adopt innovative technologies while meeting regulatory standards reinforces their pivotal role in this market landscape. #### **Atherectomy Devices Market Material Insights** The US Atherectomy Devices Market is significantly influenced by the choice of materials used in device manufacturing, which include Stainless Steel, Polymers, and Composites. Stainless Steel has long been a preferred choice due to its strength and durability, ensuring reliability during surgical procedures. Polymers are gaining traction for their flexibility and lightweight properties, making them suitable for various applications in minimally invasive surgeries. Composites combine the benefits of both metal and plastic, often optimizing performance while reducing weight, which is increasingly important in the development of next-generation atherectomy devices. Each material segment plays a crucial role in driving innovation and enhancing patient outcomes, as manufacturers strive to meet the evolving needs of healthcare professionals and patients in the US. The diversity in material selection fosters advancements in design and functionality, fueling market growth and expanding opportunities within the US Atherectomy Devices Market. Overall, the market segmentation based on Material highlights the essential characteristics that contribute to the effectiveness of atherectomy procedures while responding to the growing demands within the healthcare sector. ### **US Atherectomy Devices Market Key Players and Competitive Insights** The US Atherectomy Devices Market is characterized by intense competition among key players who focus on innovation and the development of advanced technologies to improve the treatment of cardiovascular diseases. The market comprises a variety of devices designed to remove atherosclerotic plaque from blood vessels, ensuring better outcomes for patients suffering from peripheral and coronary artery diseases. As the prevalence of these conditions increases, driven by factors such as an aging population and rising obesity rates, competition has prompted manufacturers to expand product portfolios and optimize their offerings. Strategic partnerships, collaborations, and mergers are common practices among established and emerging companies looking to enhance their market presence. Furthermore, regulatory approvals and the introduction of cutting-edge technologies such as laser and directional atherectomy are reshaping market dynamics, allowing for more effective treatment solutions that encourage patient recovery and satisfaction. Eagle Medical has made a significant mark in the US Atherectomy Devices Market through its commitment to delivering innovative products and solutions that address critical healthcare needs. The company's strength lies in its robust research and development capabilities, enabling it to create advanced atherectomy devices that cater specifically to the requirements of medical professionals and patients. With a strong emphasis on product quality and efficiency, Eagle Medical has built a reputation for reliability and high performance in medical devices. The company's strategic focus on maintaining strong relationships with healthcare providers has allowed it to establish a solid market presence across various regions in the United States, ensuring that its products are accessible where they are needed most. SentreHEART is recognized as a key player in the US Atherectomy Devices Market, leveraging its robust technology portfolio to develop solutions that enhance patient outcomes in cardiovascular care. The company offers a range of innovative products, with a particular emphasis on devices designed for the treatment of complex vascular challenges. SentreHEART's strengths lie in its ability to integrate cutting-edge technology with clinical expertise, fostering trust among healthcare professionals. The company has strategically pursued mergers and acquisitions to enhance its product offerings and expand its market foothold, strengthening its competitive edge. This strategic growth allows SentreHEART to provide comprehensive solutions aligned with the evolving needs of the healthcare industry, ensuring that it remains at the forefront of advancements in atherectomy technology within the US market. #### **Key Companies in the US Atherectomy Devices Market Include** ### **US Atherectomy Devices Market Industry Developments** The US Atherectomy Devices Market has recently seen significant developments, including increased investment in innovative technologies and clinical advancements. Companies like Medtronic, Abbott Laboratories, and Boston Scientific are at the forefront, with ongoing Research and Development initiatives aimed at enhancing the efficacy of their atherectomy devices. The market is experiencing growth due to rising incidences of cardiovascular diseases, with the US Centers for Disease Control and Prevention emphasizing the need for advanced treatment options. In terms of mergers and acquisitions, there have been notable movements in the market. In June 2023, Boston Scientific announced its acquisition of an innovative atherectomy technology company, further solidifying its market position. Additionally, in March 2022, Cardiovascular Systems acquired the rights to a new device, expanding its product portfolio. Over the past few years, major regulatory approvals have also been granted, allowing for a broader range of treatment options for patients suffering from peripheral artery disease. As a result, the market valuation for atherectomy devices in the US is on the rise, positively impacting the competitive landscape and expanding accessibility for patients in need of these critical medical interventions. ### **US Atherectomy Devices Market Segmentation Insights** #### **Atherectomy Devices Market Type Outlook** #### **Atherectomy Devices Market Application Outlook** #### **Atherectomy Devices Market End User Outlook** #### **Atherectomy Devices Market Material Outlook** ## Market Drivers ### Healthcare Infrastructure Improvements Improvements in healthcare infrastructure across the US are significantly impacting the atherectomy devices market. Enhanced facilities and increased access to advanced medical technologies are facilitating the adoption of innovative treatment options. As hospitals and clinics upgrade their equipment and capabilities, the integration of atherectomy devices into standard practice becomes more feasible. The atherectomy devices market is poised to benefit from these infrastructural advancements, as they enable healthcare providers to offer a wider range of services. Additionally, the expansion of outpatient facilities and specialized cardiovascular centers is likely to increase the volume of atherectomy procedures performed, further driving market growth. ### Technological Innovations in Device Design Technological innovations play a crucial role in shaping the atherectomy devices market. Continuous advancements in device design, such as the development of more efficient and user-friendly systems, are enhancing the effectiveness of atherectomy procedures. For instance, the introduction of laser and rotational atherectomy devices has improved the precision of plaque removal, leading to better patient outcomes. The atherectomy devices market is witnessing a surge in research and development activities, with companies investing heavily in innovative technologies. This focus on innovation is expected to drive market growth, as healthcare providers seek the latest solutions to improve procedural success rates and patient safety. ### Aging Population and Associated Health Issues The aging population in the US is a significant factor influencing the atherectomy devices market. As individuals age, the incidence of cardiovascular diseases tends to increase, leading to a higher demand for effective treatment options. Current statistics indicate that approximately 80% of individuals over 65 years old have at least one chronic health condition, with cardiovascular diseases being prevalent. This demographic shift is expected to drive the atherectomy devices market, as healthcare systems adapt to meet the needs of an older population. The increasing prevalence of conditions such as atherosclerosis necessitates the use of atherectomy devices, which are designed to remove plaque from arteries, thereby improving patient outcomes. ### Increasing Demand for Minimally Invasive Procedures The growing preference for minimally invasive procedures is a notable driver in the atherectomy devices market. Patients and healthcare providers alike are increasingly favoring techniques that reduce recovery time and minimize surgical risks. This trend is reflected in the rising number of procedures performed, with estimates suggesting that minimally invasive surgeries account for over 60% of all cardiovascular interventions in the US. As a result, the demand for atherectomy devices, which facilitate such procedures, is expected to rise. The atherectomy devices market is likely to benefit from this shift, as advancements in device technology continue to enhance efficacy and safety, further encouraging adoption among healthcare professionals. ### Rising Awareness and Education on Cardiovascular Health Increasing awareness and education regarding cardiovascular health are pivotal in driving the atherectomy devices market. Public health campaigns and educational initiatives have heightened understanding of cardiovascular diseases and the importance of early intervention. As awareness grows, more patients are seeking treatment options, leading to an uptick in procedures that utilize atherectomy devices. The atherectomy devices market is likely to benefit from this trend, as healthcare providers are encouraged to adopt these devices in their treatment protocols. Furthermore, the emphasis on preventive care and early diagnosis is expected to result in a higher demand for atherectomy procedures, thereby propelling market growth. ## Future Outlook The [Atherectomy Devices Market](https://www.marketresearchfuture.com/reports/atherectomy-devices-market-7322) is projected to grow at a 6.55% CAGR from 2025 to 2035, driven by technological advancements, increasing cardiovascular diseases, and rising healthcare expenditure. **New opportunities:** - Development of minimally invasive atherectomy systems for outpatient procedures. - - Expansion of telehealth services for remote patient monitoring and follow-up. - Partnerships with hospitals for integrated atherectomy device training programs. By 2035, the atherectomy devices market is expected to achieve substantial growth and innovation. ## Segment Insights ### By Type: Directional Atherectomy Devices (Largest) vs. Laser Atherectomy Devices (Fastest-Growing) In the US atherectomy devices market, Directional Atherectomy Devices hold a significant share, driven by their established technology and efficacy in treating complex lesions. These devices are particularly favored in clinical settings due to their ability to achieve optimal vessel clearance. Conversely, Orbital and Rotational Atherectomy Devices maintain a smaller portion of the market share but are gaining traction in specific use cases due to their unique mechanisms of action. Growth trends indicate a robust interest in Laser Atherectomy Devices, recognized as the fastest-growing segment due to advancements in laser technologies that enhance precision and reduce recovery times. This growth is spurred by increasing patient demands for minimally invasive procedures and favorable clinical outcomes associated with these devices. The overall trend toward outpatient services further supports the adoption of innovative atherectomy technologies. Directional Atherectomy Devices (Dominant) vs. Orbital Atherectomy Devices (Emerging) Directional Atherectomy Devices are characterized by their capability to navigate complex arterial structures effectively, making them the dominant choice among healthcare providers in the US atherectomy devices market. Their design allows for precision targeting of lesions, leading to successful outcomes in peripheral and coronary interventions. On the other hand, Orbital Atherectomy Devices are emerging as a viable alternative, utilizing a novel mechanism that enables the removal of calcified plaque while preserving healthy tissue. Though currently less prevalent, the growing clinical evidence supporting their effectiveness is likely to enhance their adoption rate in the near future, contributing to an evolving competitive landscape. ### By Application: Coronary Artery Disease (Largest) vs. Peripheral Artery Disease (Fastest-Growing) In the US atherectomy devices market, the application segment is significantly dominated by the treatment of coronary artery disease, which captures the largest share among its counterparts. This condition's prevalence, driven by increasing risk factors such as sedentary lifestyles and aging populations, contributes to its commanding market presence. While coronary artery disease leads in share, peripheral artery disease is emerging rapidly, reflecting increasing awareness and diagnostic capabilities that prompt early intervention. Growth trends in the US atherectomy devices market are profoundly influenced by the rising incidence of vascular diseases and advancements in atherectomy technologies. The peripheral artery disease segment, in particular, is gaining traction due to enhanced patient accessibility to treatment options and robust marketing strategies. As healthcare providers emphasize improved outcomes and less invasive procedures, the adoption of atherectomy devices in treating peripheral artery disease is expected to surge, making it the fastest-growing segment in this market. Coronary Artery Disease (Dominant) vs. Carotid Artery Disease (Emerging) Coronary artery disease remains the dominant application in the US atherectomy devices market, characterized by its extensive treatment protocols and high patient volumes. Its prominence is attributed to the high rates of heart-related diseases in the aging population, as well as established clinical guidelines that prioritize atherectomy as an effective treatment. Conversely, carotid artery disease, while emerging, is gaining interest due to an increasing recognition of its impact on stroke prevention. The market for atherectomy devices treating carotid artery disease is expanding as healthcare providers adopt more advanced technologies, enhancing the procedural success rate and patient outcomes. This trend is fuelled by ongoing research and development, which continues to refine atherectomy techniques and tools, thus fostering growth in this segment. ### By End User: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing) In the US atherectomy devices market, hospitals command the largest share among the end user segments, reflecting their pivotal role in providing critical cardiac care. They are equipped with advanced facilities and specialized personnel, enabling the execution of complex atherectomy procedures. Meanwhile, ambulatory surgical centers are gaining traction, showcasing a significant rise due to their efficiency and cost-effectiveness, appealing to a broader patient demographic. The growth trends within the end-user segments indicate a robust shift towards minimally invasive procedures, particularly in ambulatory surgical centers. This shift is driven by the increasing demand for outpatient services, along with technological advancements that facilitate quicker recovery times. Furthermore, hospitals continue to innovate in their procedures and equipment, sustaining their dominance while adapting to new healthcare paradigms. Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging) Hospitals hold a dominant position in the US atherectomy devices market due to their comprehensive healthcare services and specialized cardiology units. They are equipped with cutting-edge technology, allowing them to perform a wide range of complex procedures efficiently. On the other hand, ambulatory surgical centers are emerging rapidly, characterized by their ability to offer outpatient procedures at reduced costs. These centers prioritize patient convenience and shorter wait times, aligning with the growing trend for less invasive treatments. As both segments evolve, hospitals focus on enhancing service delivery, while ambulatory surgical centers capitalize on flexibility and patient-centric care to attract a larger patient base. ### By Material: Stainless Steel (Largest) vs. Polymers (Fastest-Growing) In the US atherectomy devices market, Stainless Steel leads the material segment with a significant share due to its high strength and durability. Polymers, while currently a smaller segment, are rapidly gaining traction thanks to advancements in biocompatibility and flexibility, catering to a growing demand for minimally invasive procedures. Composites remain a niche player, attracting attention for their unique properties, but have yet to achieve substantial market penetration. Growth in the material segment is driven by technological innovations and an increasing preference for safer, more effective treatment options. The healthcare industry's shift towards less invasive methods is propelling the use of Polymers, heralding their emergence as a viable alternative to traditional materials. Additionally, changing regulations and a greater focus on patient outcomes are encouraging manufacturers to invest in research and development of advanced materials, ensuring a dynamic market landscape. Stainless Steel (Dominant) vs. Polymers (Emerging) Stainless Steel remains the dominant material in the US atherectomy devices market, providing essential features such as strength and resistance to corrosion, making it the preferred choice for many medical professionals. Its established reliability and track record facilitate its widespread use in various atherectomy procedures. Conversely, Polymers are viewed as an emerging alternative due to their lightweight properties and potential for customization, offering flexibility in design that enhances patient comfort. Despite being newer to the market, Polymers are increasingly favored in procedures where minimizing tissue damage is critical. As research continues to validate their safety and performance, Polymers are poised to make a significant impact in the market. ## Competitive Benchmarking The atherectomy devices market is characterized by a dynamic competitive landscape, driven by technological advancements and an increasing prevalence of cardiovascular diseases. Major players such as Boston Scientific (US), Medtronic (US), and Abbott Laboratories (US) are at the forefront, focusing on innovation and strategic partnerships to enhance their market positions. Boston Scientific (US) emphasizes the development of minimally invasive solutions, while Medtronic (US) is leveraging its extensive portfolio to integrate advanced technologies into its devices. Abbott Laboratories (US) appears to be concentrating on expanding its product offerings through acquisitions, thereby enhancing its competitive edge in this evolving market.Key business tactics employed by these companies include localizing manufacturing and optimizing supply chains to improve efficiency and reduce costs. The market structure is moderately fragmented, with several players vying for market share. However, the collective influence of key players like Boston Scientific (US) and Medtronic (US) suggests a trend towards consolidation, as these companies seek to leverage their strengths to capture a larger share of the market. In October Boston Scientific (US) announced the launch of its latest atherectomy device, which incorporates advanced imaging technology to enhance procedural outcomes. This strategic move is likely to position the company as a leader in innovation, potentially attracting a broader customer base and increasing its market share. The integration of imaging technology into atherectomy procedures may also improve patient outcomes, thereby reinforcing Boston Scientific's commitment to enhancing healthcare quality. In September Medtronic (US) entered into a partnership with a leading telehealth provider to integrate remote monitoring capabilities into its atherectomy devices. This collaboration is indicative of a broader trend towards digital health solutions, suggesting that Medtronic is keen on enhancing patient engagement and improving post-procedural care. By incorporating telehealth features, Medtronic may not only improve patient outcomes but also streamline its operational processes, thereby gaining a competitive advantage. In August Abbott Laboratories (US) completed the acquisition of a smaller medical device company specializing in innovative atherectomy technologies. This acquisition is expected to bolster Abbott's product portfolio and enhance its R&D capabilities, allowing the company to accelerate the development of next-generation devices. Such strategic moves indicate Abbott's commitment to maintaining a competitive edge through innovation and diversification. As of November current competitive trends in the atherectomy devices market include a strong emphasis on digitalization, sustainability, and the integration of artificial intelligence (AI) into device functionalities. Strategic alliances are increasingly shaping the landscape, as companies recognize the value of collaboration in driving innovation. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition towards a focus on technological advancements, reliability in supply chains, and the ability to deliver superior patient outcomes. This shift underscores the importance of innovation as a key driver of success in the atherectomy devices market. ## Recent News & Developments The US Atherectomy Devices Market has recently seen significant developments, including increased investment in innovative technologies and clinical advancements. Companies like Medtronic, Abbott Laboratories, and Boston Scientific are at the forefront, with ongoing Research and Development initiatives aimed at enhancing the efficacy of their atherectomy devices. The market is experiencing growth due to rising incidences of cardiovascular diseases, with the US Centers for Disease Control and Prevention emphasizing the need for advanced treatment options. In terms of mergers and acquisitions, there have been notable movements in the market. In June 2023, Boston Scientific announced its acquisition of an innovative atherectomy technology company, further solidifying its market position. Additionally, in March 2022, Cardiovascular Systems acquired the rights to a new device, expanding its product portfolio. Over the past few years, major regulatory approvals have also been granted, allowing for a broader range of treatment options for patients suffering from peripheral artery disease. As a result, the market valuation for atherectomy devices in the US is on the rise, positively impacting the competitive landscape and expanding accessibility for patients in need of these critical medical interventions. ## Report Scope | MARKET SIZE 2024 | 427.81(USD Million) | | --- | --- | | MARKET SIZE 2025 | 455.83(USD Million) | | MARKET SIZE 2035 | 860.0(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.55% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Boston Scientific (US), Medtronic (US), Abbott Laboratories (US), Cardiovascular Systems Inc (US), Spectranetics (US), B. Braun Melsungen AG (DE), Terumo Corporation (JP), Philips (NL) | | Segments Covered | Type, Application, End User, Material | | Key Market Opportunities | Advancements in minimally invasive techniques enhance growth potential in the atherectomy devices market. | | Key Market Dynamics | Technological advancements and regulatory changes drive innovation and competition in the atherectomy devices market. | | Countries Covered | US | ## Frequently Asked Questions **Q: What is the current valuation of the US atherectomy devices market?** A: The market valuation was $427.81 Million in 2024. **Q: What is the projected market size for the US atherectomy devices market by 2035?** A: The market is projected to reach $860.0 Million by 2035. **Q: What is the expected CAGR for the US atherectomy devices market during the forecast period 2025 - 2035?** A: The expected CAGR is 6.55% during the forecast period 2025 - 2035. **Q: Which companies are the key players in the US atherectomy devices market?** A: Key players include Boston Scientific, Medtronic, Abbott Laboratories, and Cardiovascular Systems Inc. **Q: What are the main types of atherectomy devices available in the market?** A: The main types include Directional, Orbital, Laser, and Rotational Atherectomy Devices. **Q: What was the market size for Directional Atherectomy Devices in 2024?** A: The market size for Directional Atherectomy Devices was $85.0 Million in 2024. **Q: How does the market for Peripheral Artery Disease atherectomy devices compare to Coronary Artery Disease devices?** A: The market for Peripheral Artery Disease devices was $200.0 Million, compared to $150.0 Million for Coronary Artery Disease devices in 2024. **Q: What is the expected market size for Ambulatory Surgical Centers in the atherectomy devices market?** A: The expected market size for Ambulatory Surgical Centers is projected to be $157.81 Million in 2024. **Q: What materials are commonly used in the manufacturing of atherectomy devices?** A: Common materials include Stainless Steel, Polymers, and Composites. **Q: What was the market size for Laser Atherectomy Devices in 2024?** A: The market size for Laser Atherectomy Devices was $95.0 Million in 2024. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-atherectomy-devices-market-18631*